Study guide

Malignant Hemispheric & Cerebellar Infarction

ABPN Neurocritical Care Study Guide Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Neurologic Examination & Coma Assessment in the ICU

Current Examination, Blueprint & Preparation Neurologic Examination in Critically Ill Patients Coma Evaluation & Consciousness Alterations Delirium & Toxic-Metabolic Encephalopathy in the ICU

2 Chapter 2: Cerebral Physiology & Intracranial Dynamics

Cerebral Blood Flow, Metabolism & Autoregulation Intracranial Pressure & Compliance Cerebral Edema & Herniation Syndromes

3 Chapter 3: Intracranial Hypertension & Cerebral Perfusion Management

Tiered ICP Management Protocols Hyperosmolar Therapy & Fluid Management Advanced & Refractory ICP Interventions

4 Chapter 4: Airway, Mechanical Ventilation & Pulmonary ICU Management

Emergency Airway Management & Neuro-Intubation Mechanical Ventilation Strategies in Acute Brain Injury Tracheostomy & Ventilator Weaning in Neurocritical Care Pulmonary Complications in the Neuro-ICU Obstructive Lung Disease, Pulmonary Hypertension & Bronchoscopy

5 Chapter 5: Hemodynamics, Shock & Cardiovascular Management

Hemodynamic Monitoring & Blood Pressure Targets Vasoactive Agents: Inotropes, Vasopressors & Antihypertensives Cardiac Complications of Brain Injury

6 Chapter 6: Neuropharmacology, Analgesia & Sedation

ICU Sedation & Analgesia Neuromuscular Blockade & Monitoring Propofol Infusion Syndrome & Drug Toxicities Antiseizure Drug Pharmacology in the ICU

7 Bleeding, Thrombosis & Hematologic Emergencies

Warfarin & Heparin Reversal Direct Oral Anticoagulant (DOAC) Reversal Antiplatelet Management & Platelet Dysfunction Venous Thromboembolism Prophylaxis & Management Transfusion, Coagulopathy, TMA & Cellular-Therapy Neurotoxicity

8 Chapter 8: Systemic ICU Care, Fluids, Electrolytes & Endocrine

Hyponatremia & Osmoregulation: SIADH vs Cerebral Salt Wasting Diabetes Insipidus, Hypernatremia & Endocrine Crises Critical Care Prophylaxis, Nutrition & Infection Prevention

9 Systemic Trauma & Environmental Injury

Polytrauma, Chest Injury & Abdominal Hemorrhage Burns, Electrical Injury & Hanging

10 Cardiac Emergencies & Mechanical Support

IABP, Ventricular Devices & ECMO Acute Coronary, Valvular, Rhythm & Aortic Emergencies

11 Kidney Injury, Acid–Base & Renal Replacement

Acute Kidney Injury & Renal Drug Clearance Acid–Base Disorders, Electrolytes & Renal Replacement

12 Systemic Infection & Endocrine Emergencies

Sepsis, Endocarditis & Antimicrobial Principles Thyroid, Adrenal & Dysglycemic Emergencies

13 Gastrointestinal & Hepatic Emergencies

Acute Abdomen, GI Bleeding & Abdominal Compartment Syndrome Acute Liver Failure, Cirrhosis & Hepatic Drug Effects

14 Chapter 9: Neuroimaging in the Neuro-ICU

Non-Contrast CT & CT Angiography CT Perfusion & Advanced Perfusion Imaging Magnetic Resonance Imaging in Critical Illness

15 Chapter 10: Electrophysiology & Neuromonitoring

Continuous EEG & ACNS Standardized Critical Care Terminology Invasive Neuromonitoring: ICP & External Ventricular Drains Multimodal Monitoring: PbtO2, Microdialysis & Transcranial Doppler

16 Angiography, Electrodiagnosis & CSF Analysis

Conventional Angiography & Cranial–Spinal Shunts EMG, Nerve Conduction & Acute Muscle Disease CSF Analysis: Infection, Inflammation & Hemorrhage

17 Chapter 11: Bedside Procedures, Ultrasound & Death by Neurologic Criteria

Critical Care Procedural Skills Critical Care Ultrasound & Echocardiography Determination of Death by Neurologic Criteria

18 Chapter 12: Acute Ischemic Stroke & Reperfusion Therapies

Acute Ischemic Stroke Management & Thrombolysis Endovascular Thrombectomy & Large Vessel Occlusion Malignant Hemispheric & Cerebellar Infarction

19 Chapter 13: Spontaneous Intracerebral Hemorrhage & Intraventricular Hemorrhage

Acute Intraparenchymal Hemorrhage Management Intraventricular Hemorrhage & Hydrocephalus Surgical Evacuation & Minimally Invasive Surgery in ICH

20 Chapter 14: Aneurysmal Subarachnoid Hemorrhage & Delayed Cerebral Ischemia

Aneurysmal Subarachnoid Hemorrhage: Acute Resuscitation & Securing Delayed Cerebral Ischemia & Cerebral Vasospasm Non-Aneurysmal Subarachnoid Hemorrhage & Vascular Malformations

21 Venous, Spinal & Traumatic Vascular Disease

Cerebral Venous Thrombosis & Spinal Cord Infarction Traumatic Dissection, Carotid–Cavernous Fistula & Penetrating Injury

22 Chapter 15: Traumatic Brain & Spinal Cord Injury

Severe Traumatic Brain Injury & Contusions Acute Traumatic Spinal Cord Injury & Neurogenic Shock Spine Trauma, Fractures & Cord Syndromes

23 Chapter 16: Status Epilepticus, Seizures & Neuromuscular Emergencies

Status Epilepticus: Convulsive & Non-Convulsive Refractory & Super-Refractory Status Epilepticus Acute Neuromuscular Respiratory Failure

24 Chapter 17: Post-Cardiac Arrest Care, CNS Infections & Encephalitis

Targeted Temperature Management & Post-Cardiac Arrest Care Post-Cardiac Arrest Neuroprognostication Acute CNS Infections, Encephalitis & Inflammatory Emergencies

25 Neuroinflammation & Neurooncology

Fulminant Demyelination & Autoimmune Encephalitis Brain, Spinal & Leptomeningeal Cancer Emergencies

26 Pregnancy, Transplantation & Pediatric Care

Pregnancy, Postpartum & Post-Transplant Neurologic Care Pediatric Neurocritical Care

27 Chapter 18: Neurosurgical & Perioperative Emergencies

Postoperative Neurosurgical Complications Device Complications: EVDs, Shunts & ICP Monitors Cerebral Hyperperfusion Syndrome & Post-Interventional Emergencies

28 Chapter 19: Ethics, Palliative Care & Organ Donation in the Neuro-ICU

Communication, Surrogate Decision-Making & Conflict Resolution Neuroprognostication Ethics, Withdrawal of Life Support & Palliative Care Organ Donation & Management of the Deceased Donor

Malignant Hemispheric & Cerebellar Infarction

Key Takeaways Explain This Topic AI

Large hemispheric infarctions require close surveillance for declining consciousness, mass effect, and herniation, with early neurosurgical referral.

In selected patients aged 60 or younger, decompression within 48 hours substantially improves survival and shifts functional outcomes.

DESTINY II supports a survival benefit in older patients, with frequent substantial dependency; mRS 3 is not full independence and mRS 5 is not vegetative state.

Cerebellar infarction with symptomatic hydrocephalus may need ventriculostomy; deterioration from brainstem compression requires urgent consideration of suboccipital decompression.

Last updated: October 2026

Malignant Hemispheric & Cerebellar Infarction

Malignant ischemic infarction occurs when complete occlusion of a major cerebral or cerebellar arterial trunk leads to massive, space-occupying edema. Without timely neurosurgical decompression, progressive tissue displacement forces uncal, central, or tonsillar herniation, terminating in secondary brainstem infarction and death.

Pathophysiology & Biomechanics of Malignant Edema

Malignant middle cerebral artery ( M C A MCA MC A ) infarction affects approximately 10 % 10\% 10% of all supratentorial ischemic strokes, most commonly stemming from an acute thromboembolic occlusion of the internal carotid artery ( I C A ICA I C A ) terminus or proximal M C A M 1 MCA\text{ }M1 MC A M 1 segment.

The Two-Phase Edema Cascade

Cytotoxic Edema (Hours 0 – 24 0\text{--}24 0 – 24 ): Acute cessation of blood flow depletes intracellular ATP, arresting the N a + / K + Na^+/K^+ N a + / K + ATPase pump. Sodium, chloride, and water pour into astrocytic foot processes and neurons, causing cellular swelling while total brain tissue volume remains initially constant.

Vasogenic Edema (Hours 24 – 96 24\text{--}96 24 – 96 ): Endothelial cell death, up-regulation of matrix metalloproteinases ( M M P - 9 MMP\text{-}9 MMP - 9 ), and breakdown of capillary tight junctions (zonula occludens) compromise the blood-brain barrier. Plasma water, albumin, and macromolecules leak into the extracellular parenchymal space, generating massive tissue expansion.

Temporal Peak: In malignant infarction, cerebral edema typically peaks between day 2 and day 4 (48 to 96 hours post-stroke) . Under medical therapy alone (hyperosmolar therapy, sedation, hyperventilation), mortality reaches 70 – 80 % 70\text{--}80\% 70 – 80% , primarily driven by uncal transtentorial herniation compressing the midbrain, stretching paramedian perforating vessels (Duret hemorrhages), and extinguishing brainstem function.

Early Predictors of Malignant Progression

Recognizing impending malignant edema before irreversible clinical deterioration occurs is vital for timely surgical referral.

Predictor Domain High-Risk Features for Malignant Edema Progression

Patient Demographics Younger age ( < 60 years < 60\text{ years} < 60 years ): Absence of age-related cerebral atrophy leaves minimal intracranial CSF reserve to buffer swelling

Neurological Deficit Baseline NIHSS > 15 – 20 > 15\text{--}20 > 15 – 20 for non-dominant hemispheric stroke; baseline NIHSS > 20 > 20 > 20 for dominant hemispheric stroke within 6 hours

Early CT Hypodensity Hypodensity involving > 50 % > 50\% > 50% of the MCA territory or ASPECTS ≤ 4 \le 4 ≤ 4 within 12 hours of onset

Vascular Territories "MCA-plus" syndrome: Concomitant infarction in adjacent anterior cerebral artery ( A C A ACA A C A ) or posterior cerebral artery ( P C A PCA PC A ) territories

Mass Effect / Midline Shift Septum pellucidum displacement ≥ 5 mm \ge 5\text{ mm} ≥ 5 mm or pineal gland displacement ≥ 3 mm \ge 3\text{ mm} ≥ 3 mm within 24–48 hours

Vascular Imaging Absence of pial collateral circulation on CTA; carotid T-occlusion; TCD pulsatility index > 1.5 > 1.5 > 1.5

  • Decompressive Hemicraniectomy for Supratentorial Stroke
  • Surgical Technique and Timing

A sufficiently large frontotemporoparietal decompression with dural expansion is important to relieve swelling and avoid constriction at the bone edges. Common operative dimensions are approximately 12–15 cm or larger depending on anatomy. This is a specialist technical principle rather than a universal contraindication defined by one measured diameter. Refer before irreversible deterioration; osmotherapy and brief rescue ventilation can bridge to definitive assessment, but do not replace indicated decompression.

  • Landmark Randomized Trial Evidence
  • Patients Aged ≤ 60 \le 60 ≤ 60 Years: The Pooled Analysis

The European pooled analysis of three prospective randomized trials— DECIMAL , DESTINY , and HAMLET —evaluated decompressive hemicraniectomy within 48 hours in patients ≤ 60 \le 60 ≤ 60 years of age with malignant MCA infarction:

Mortality Reduction: Surgery reduced 1-year mortality from 71 % 71\% 71% to 22 % 22\% 22% (absolute risk reduction of 49 % 49\% 49% , N N T = 2 NNT = 2 NNT = 2 ).

Survival with mRS at most 3: Surgery doubled the proportion of patients achieving survival with no worse than moderate disability, which may still require help ( 43 % 43\% 43% vs 21 % 21\% 21% , N N T = 4 NNT = 4 NNT = 4 ).

Outcome counseling: mRS 5 denotes severe dependency, not vegetative state. Describe the entire outcome distribution and the patient’s values rather than equating survival with independence.

Patients Older Than 60: DESTINY II

Among patients aged 61–82 treated within 48 hours, six-month mortality was 33% with surgery versus 70% with medical treatment. No patient achieved mRS 0–2. The respective mRS distributions were 7% versus 3% at mRS 3, 32% versus 15% at mRS 4, and 28% versus 13% at mRS 5. Thus surgery improved survival but many survivors needed substantial help. mRS 3 allows walking without another person's assistance while requiring some help; mRS 4 means inability to walk or attend bodily needs without assistance, and mRS 5 means severe dependency with constant care. None of these scores by itself defines consciousness or quality of life.

Discuss these possible outcomes with the surrogate in relation to the patient's preferences and baseline function. Age alone does not resolve the decision, and trial group averages do not determine an individual's outcome. State the timing and population of the study rather than applying one percentage to every large infarction.

Malignant Cerebellar Infarction & Posterior Fossa Decompression

Malignant infarction of the cerebellum—most frequently resulting from posterior inferior cerebellar artery ( P I C A PICA P I C A ) or superior cerebellar artery ( S C A SCA SC A ) occlusion—presents unique mechanical dangers due to the tight confines of the posterior fossa.

Posterior Fossa Compartment Dynamics

The infratentorial compartment is bounded superiorly by the rigid, non-compliant tentorium cerebelli and inferiorly by the foramen magnum. Expanding cerebellar edema triggers a sequential cascade:

Effacement of the fourth ventricle and perimedullary / prepontine cisterns.

Acute obstructive (non-communicating) hydrocephalus from fourth ventricle or cerebral aqueduct occlusion.

Downward tonsillar herniation: Cerebellar tonsils impact into the foramen magnum, causing direct medullary compression, respiratory arrest, and death.

Upward transtentorial herniation: Swollen cerebellar vermis herniates upward through the tentorial incisura into the ambient cistern, compressing the midbrain and posterior cerebral arteries.

Neurosurgical Interventions & The EVD Trap

Definitive treatment for malignant cerebellar infarction with fourth ventricle compression, brainstem distortion, or altered consciousness is emergent suboccipital decompressive craniectomy ( S D C SDC S D C ) with expansile duraplasty, foramen magnum decompression, and resection of non-viable necrotic cerebellar tissue.

Warning

Ventriculostomy is recommended for symptomatic obstructive hydrocephalus after cerebellar infarction. Selected patients can improve with careful CSF diversion alone, while neurologic deterioration from brainstem compression despite medical treatment requires suboccipital decompression. Avoid uncontrolled drainage and reassess urgently: hydrocephalus, infarct size, brainstem compression, clinical trajectory, and response determine whether decompression is also needed. EVD monotherapy is not universally a fatal error.